Chrome Extension
WeChat Mini Program
Use on ChatGLM

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.

Frontiers in Endocrinology(2022)

Cited 0|Views11
No score
Abstract
[This corrects the article DOI: 10.3389/fendo.2021.662865.].
More
Translated text
Key words
clinical trial,cortisol,Cushing syndrome,glucocorticoid,hypercortisolism,hyperglycemia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined